Basic Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2757-2768
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2757
Table 1 Collected tissue and plasma samples
Specimen type
Specimen origin
Specimen number
PlasmaPatients with primary GC39 (female, 44-85 yr)
61 (male, 42-85 yr)
Healthy subjects100 (40-88 yr)
Preoperative and postoperative paired samples21
Patients with benign gastric lesions15
Patients with precancerous lesions15
TissueGastric cancer tissues20
Matching para-cancerous tissues20
Table 2 The intra-assay and inter-assay repeatability of circ_0004592 and 18S rRNA

Intra-assay
Inter-assay
mean ± SD, CV (%)
mean ± SD, CV (%)
Circ_000459223.23 ± 0.48, 2.0624.01 ± 0.91, 3.79
18S rRNA15.32 ± 0.28, 1.8314.87 ± 0.56, 3.77
Table 3 The correlation between circ_0004592 expression and clinicopathological parameters of gastric cancer patients
Characteristics
No. of patients
Low expression
High expression
P value
Gender
Male6133280.206
Female391722
Age
≤ 603414200.146
> 60663630
Tumor size, cm
< 57236360.176
≥ 5281414
Pathological differentiation
Poor-undifferentiation5922370.002b
Well-moderate412813
Tumor depth
T1-T25032180.004b
T3-T4501832
Lymph node metastasis
Yes4919300.022a
No513120
Nerve/vascular invasion
Positive4822260.274
Negative522824
CEA
Positive6036240.012a
Negative401426
CA199
Positive5125260.500
Negative492524
Table 4 The single or combination diagnosis of circ_0004592, carcinoembryonic antigen, and cancer antigen 199

SEN, %
SPE, %
ACCU, %
PPV, %
NPV, %
Circ_000459266.00 (66/100)84.00 (84/100)75.00 (150/200)80.49 (66/82)71.19 (84/118)
CEA60.00 (60/100)77.00 (77/100)68.50 (137/200)72.29 (60/83)65.81 (77/117)
CA19951.00 (51/100)84.00 (84/100)67.50 (135/200)76.12 (51/67)63.16 (84/133)
Circ_0004592 + CEA74.00 (74/100)76.00 (76/100)75.00 (150/200)75.51 (74/98)74.51 (76/102)
Circ_0004592 + CA19967.00 (67/100)88.00 (88/100)77.50 (155/200)84.81 (67/79)72.73 (88/121)
Circ_0004592 + CEA + CA19985.00 (85/100)65.00 (65/100)75.00 (150/200)70.83 (85/120)81.25 (65/80)